Lucid helps Aston Martin with EV development

Details on what's moving the market this morning here                                                                                                                                                                                                                                                                                                                                                                                                                 *Together with American Lithium Corp (Nasdaq: AMLI) Good day, 360 – Here are our top investing ideas today – these setups look primed! Be the best prepared trader on the Street! MEDS - Up over 60% in pre-market after acquiring Superlatus on Friday BMEA - 12% higher in pre-market after releasing Positive Clinical Data this am LCID - Up over 10% in pre after announcing partnership with Aston Martin *A Message on Behalf of American Lithium Corp 🔥 Hot Stock of the Day 🔥 American Lithium Corp (Nasdaq: AMLI) Global auto manufactures are investing heavily into the lithium space to guarantee their own future. On top of that, all of the biggest lithium miners are expanding operations. That makes lithium companies in the right location extremely valuable as rich buyout targets. American Lithium Corp (AMLI) is positioning itself to be the TOP contender. AMLI has two top-tier lithium deposits that set them apart from the crowd. 👉The TLC Project is the 2nd largest measured & indicated (M&I) lithium resource in the USA 👉The Falchani Project is the 3rd largest hard rock lithium resource in the Americas Three years ago, this company traded at a paltry fraction of where it sits now. However, given the economics of its lithium projects and worldwide demand for EVs, there’s still plenty of room for the company to grow…see for yourself! [Click here to read this full American Lithium report]( And see why we couldn’t be more excited about the incredible potential of this company! *Sponsored by American Lithium Corp, please see disclosures below MEDS - Up over 60% in pre-market after acquiring Superlatus on Friday TRxADE Health (MEDS) operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. MEDS closed up 15% higher on Friday and is gapping another 60% this morning after announcing the acquisition of Superlatus. The gap higher is related to a correction issued by MEDS in the after-hours on Friday. [The company stated](: “The number of shares that Superlatus will receive upon the closing of the Merger was miscalculated due to an error in the valuation of TRxADE. TRxADE and Superlatus have subsequently amended the LOI to reflect the correct number of shares, and TRxADE is issuing this correction notice to correct the error in the Prior Press Release.” The corrected statement is as follows: “Upon closing of the Merger, shareholders of Superlatus will receive 3,839,176 shares of MEDS, valued at $58.61 per share, and comprised of (i) common shares in an amount representing 19.99% of the total issued and outstanding stock of MEDS after Closing, and (ii) the remainder in shares of a new class of MEDS non-voting preferred stock, in each case multiplied by such shareholder’s pro rata percentage ownership.” The $13.30 level has acted as support in the pre-market and will be an important area to watch. Above it, targets to the upside are $14.50, $15, $15.50 and then the pre-market high high of $18.53. Beyond that, $20 and $22 come into play. Below $13.30, there is a gap to fill at $12.20, and potential support at $11.20, $10 and another gap to fill at Friday’s close of $8.44. BMEA - 12% higher in pre-market after releasing Positive Clinical Data this am Biomea Fusion (BMEA) is a clinical-stage biopharmaceutical company, focused on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Over the weekend, [the company announced](the presentation of positive clinical data from the initial cohorts of the ongoing Phase II Study (COVALENT-111) of BMF-219 in patients with Type 2 Diabetes Mellitus at the American Diabetes Association (ADA) 83rd Scientific Sessions. The 100 mg Cohort 3 Demonstrated a 90% Response Rate and 70% Maintained or Improved Time in (Normal Glucose) Range, While Off-Treatment H.C. Wainwright raised its price target to $50 and JP Morgan raised its target to $51 this morning. The stock is up over 12% on the news in pre-market trade. BMEA found support at the $33 level in the pre-market so that will be an important area to watch. Above it, targets to the upside are $36, $37, $39 and then the pre-market high at $40.46. Beyond that, $41, $43 and $43.69 come into play. Below $33, there is a gap to fill at $30.67. LCID - Up over 10% in pre after announcing partnership with Aston Martin Lucid Group (LCID) is a technology and automotive company that engages in electric vehicle technologies business. The company designs, engineers and builds electric vehicles, EV powertrains, and battery systems. The [company announced]( this morning that it had entered into a definitive agreement to establish a long-term strategic technology partnership with Aston Martin for the integration and supply of Lucid's state-of-the-art electric vehicle powertrain and battery systems in contracts worth in excess of $450M. [As per the press release](: - Aston Martin will receive direct access to Lucid's proprietary electric powertrain technology, including its ultra-high performance twin motor drive unit, renowned battery technology, and revolutionary Wunderbox. - Aston Martin will pay Lucid technology access fees for Lucid's technologies in a combination of Aston Martin shares and phased cash payments, with Lucid becoming a shareholder in Aston Martin. - Additionally, Lucid and Aston Martin will enter into supply arrangements for Lucid's powertrain components and systems. $6 was resistance in the pre-market and now becomes an area of potential support. Above it, targets are $6.10 and then the pre-market high of $6.19. Beyond that, $6.50, $7. $7.50 and $8 come into play. Below $6, there is potential support at $5.90, $5.84 and a gap to fill at $5.47. [Economic Calendar]( To Your Success! *Please see disclosures below. Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull *PAID ADVERTISEMENT. RagingBull has been paid one hundred thousand dollars by ach bank transfer by American Lithium Corp for advertising American Lithium Corp from a period beginning on June 12, 2023 through August 12, 2023 of the same year. As a result of this advertisement and other marketing efforts, Raging Bull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of Raging Bull do not hold a position in American Lithium Corp. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of American Lithium Corp, increased trading volume, and possibly an increased share price of the American Lithium Corp securities, which may or may not be temporary and decrease once the marketing arrangement has ended. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Raging Bull can guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of any company’s financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the companies mentioned in this advertisement, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision. SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments. Our reports/releases are a commercial advertisement and are for general information purposes ONLY. A portion of our business is engaged in the marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use. A portion of RagingBull’s business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our websites, email, SMS, push notifications. This compensation is a major conflict of interest in our ability to provide unbiased reporting. Therefore, this communication should be viewed as a commercial advertisement only. Note, we periodically conduct interviews and issue stock alerts that we are not compensated for. These are purely for the purpose of company awareness, and to generate subscription revenues. In cases where a third party is involved, please note we have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Frequently, companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the corporate awareness program ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct but has not been independently verified and is not guaranteed to be correct. NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Raging Bull, or any of their owners, employees or independent contractors is not currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at https:// www. sec. gov/edgar/ searchedgar/companysearch TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied. WE MAY HOLD SECURITIES DISCUSSED. [Ragingbull.com](, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [tw]( Update your email preferences or unsubscribe [here]( © 360wallstreet 62 Calef Hwy. #233 Lee, NH 03861, United States [[beehiiv logo]Powered by beehiiv](